Nature Communications (May 2021)

FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy

  • A. J. Wood,
  • C. H. Lin,
  • M. Li,
  • K. Nishtala,
  • S. Alaei,
  • F. Rossello,
  • C. Sonntag,
  • L. Hersey,
  • L. B. Miles,
  • C. Krisp,
  • S. Dudczig,
  • A. J. Fulcher,
  • S. Gibertini,
  • P. J. Conroy,
  • A. Siegel,
  • M. Mora,
  • P. Jusuf,
  • N. H. Packer,
  • P. D. Currie

DOI
https://doi.org/10.1038/s41467-021-23217-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 12

Abstract

Read online

FKRP mutations cause muscular dystrophies with varied clinical presentations. The target of FKRP is α-dystroglycan, but here the authors show that FKRP also directs sialylation of fibronectin, a process that is essential for recruitment o collagen to the muscle basement membrane.